Lataa...
Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy
T regulatory cells (Tregs) are subsets of T lymphocytes specialized in modulating antigen-specific immune responses in vivo. Hence, Tregs represent an ideal therapeutic tool to control detrimental immune reactions. Based on solid pre-clinical results, investigators started testing the safety and eff...
Tallennettuna:
| Julkaisussa: | Front Immunol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4658444/ https://ncbi.nlm.nih.gov/pubmed/26635807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2015.00593 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|